A preclinical study conducted by a joint team from Switzerland has found that treatment outcomes for glioblastoma patients improved considerably if they received immunotherapy…
As GLP-1 use has exploded in the U.S., many companies have started discontinuing coverage of these treatments in the health…
Earth Science Tech recently completed the acquisition of Zoolzy LLC, a wholesale distributor of active pharmaceutical ingredients (“APIs”) and finished…
mRNA vaccines and therapies have had a profound effect on the way various diseases, including infectious diseases like Covid-19, are…
VERAXA Biotech and Secarna Pharmaceuticals have reported an initial in vitro proof of concept for an antibody oligonucleotide conjugate (“AOC”)…
Researchers are developing new regenerative approaches, including stem cells, 3D-printed scaffolds and smart biomaterials designed to help the body repair…
A recent study has found that patients diagnosed with glioblastoma, a deadly brain cancer, can have extended survival durations if…
A new study whose results are yet to be peer-reviewed has shown that a personalized mRNA vaccine made from the tumor…
The company combines proprietary imaging hardware, FDA-cleared AI applications, cloud software, radiology services and healthcare IT within an end-to-end platform…
Following completion of the initial phase of its collaboration with OmniAb, VERAXA will engineer the final VXA-222 candidate and conduct…